XML 68 R24.htm IDEA: XBRL DOCUMENT
v3.22.4

Other current assets | 12 Months Ended
--- | ---
Dec. 31, 2022
Subclassifications of assets, liabilities and equities [abstract] |
Other current assets | Other current assets An analysis of Other current assets is set forth below:
(€ million) | 2022 | 2021 | 2020
Tax receivables, other than corporate income taxes | 658 |  | 802 |  | 687 |
Prepaid expenses | 714 |  | 615 |  | 525 |
Other receivables(a) | 1,290 |  | 805 |  | 567 |
Interest rate derivatives measured at fair value (see Note D.20.) | — |  | 11 |  | — |
Currency derivatives measured at fair value (see Note D.20.) | 206 |  | 284 |  | 58 |
Other current financial assets(b) | 664 |  | 1,054 |  | 900 |
Total | 3,532 |  | 3,571 |  | 2,737 |
(a) This line mainly comprises advance payments to suppliers, and receivables relating to Sanofi's activities as agent under a transitional services agreement. (b) This item includes bank loans and receivables maturing in less than one year with high-grade counterparties. For 2021, this item also includes debt instruments derived from the acquisitions of Translate Bio and Kadmon (carried out in 2021) with maturities of more than 3 months at inception and less than 12 months at December 31, 2021.

X
- Definition The disclosure of other current assets. [Refer: Other current assets] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2021-01-01 -Paragraph 10 -Subparagraph e -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_10_e&doctype=Standard -URIDate 2021-03-24 + Details
Name: | ifrs-full_DisclosureOfOtherCurrentAssetsExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration